Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4046/trd.2015.78.3.161 http://scihub22266oqcxt.onion/10.4046/trd.2015.78.3.161 C4499581!4499581!26175767     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26175767&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Tuberc+Respir+Dis+(Seoul) 2015 ; 78 (3): 161-7 Nephropedia Template TP {{tp|p=26175767|t=2015. Treatment of Drug Susceptible Pulmonary Tuberculosis |pdf=|usr=}}{{26175767}} gab.com Text Treatment of Drug Susceptible Pulmonary Tuberculosis JO: Tuberc Respir Dis (Seoul) http://www.kidney.de/pget.php?&tw=1&pmid=26175767 #FOAvip Tuberculosis (TB) remains a major global health problem, and the incidence of TB cases has not significantly decreased over the past decade in Korea. The standard short course regimen is highly effective against TB, but requires multiple TB-specific drugs and a long treatment duration. Recent studies using late-generation fluoroquinolones and/or high-dose rifapentine-containing regimens to shorten the duration of TB treatment showed negative results. Extending the treatment duration may be considered in patients with cavitation on the initial chest radiograph and positivity in sputum culture at 2 months of treatment for preventing TB relapse. Current evidence does not support the use of fixed-dose combinations compared to separate drugs for the purpose of improving treatment outcomes. All patients receiving TB treatment should be monitored regularly for response to therapy, facilitation of treatment completion, and management of adverse drug reactions. Mild adverse effects can be managed with symptomatic therapy and changing the timing of the drug administration, but severe adverse effects require a discontinuation of the offending drugs. Twit Text FOAVip Treatment of Drug Susceptible Pulmonary Tuberculosis ????Tuberc Respir Dis (Seoul) http://www.kidney.de/pget.php?&tw=1&pmid=26175767 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26175767 #FOAvip English Wikipedia <ref>{{Cite pmid|26175767}}</ref> Treatment of Drug Susceptible Pulmonary Tuberculosis #MMPMID26175767 Shin HJ; Kwon YS Tuberc Respir Dis (Seoul) 2015[Jul]; 78 (3): 161-7 PMID26175767show ga Tuberculosis (TB) remains a major global health problem, and the incidence of TB cases has not significantly decreased over the past decade in Korea. The standard short course regimen is highly effective against TB, but requires multiple TB-specific drugs and a long treatment duration. Recent studies using late-generation fluoroquinolones and/or high-dose rifapentine-containing regimens to shorten the duration of TB treatment showed negative results. Extending the treatment duration may be considered in patients with cavitation on the initial chest radiograph and positivity in sputum culture at 2 months of treatment for preventing TB relapse. Current evidence does not support the use of fixed-dose combinations compared to separate drugs for the purpose of improving treatment outcomes. All patients receiving TB treatment should be monitored regularly for response to therapy, facilitation of treatment completion, and management of adverse drug reactions. Mild adverse effects can be managed with symptomatic therapy and changing the timing of the drug administration, but severe adverse effects require a discontinuation of the offending drugs. äTreatment of Drug Susceptible Pulmonary Tuberculosis (epmc).pdf DeepDyve Pubget Overpricing